The Effects of Low-Dose Versus High-Dose Intravenous IRON Therapy With Ferric DerisomaltOSE in Patients With Chronic Heart Failure and Iron Deficiency
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 114 participants.
Also called NCT06427343
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 114 participants
- Registry
-
NCT06427343
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT06427343. Randomized; single masking; primary purpose treatment. Start 2023-10-01 (actual); primary completion 2027-08-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Effects of Low-Dose Versus High-Dose Intravenous IRON Therapy With Ferric DerisomaltOSE in Patients With Chronic Heart Failure and Iron Deficiency
- Acronym
- IRONDOSE
- Condition
- Heart Failure
- Condition
- Iron Deficiency
- Intervention (Drug)
- High-dose ferric derisomaltose
- Intervention (Drug)
- Low-dose ferric derisomaltose
- Lead sponsor
- China-Japan Friendship Hospital
Record details
- Record id
cardio:ct-nct06427343- Content hash
6a3ca59226bc19573a19b62f2e7de7838d864144d7994a507cf6fdf69a385803